Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03874351 · ClinicalTrials.gov registry record · NA
A Study of Home-Delivered Neurostimulation for Migraine
A NA study of Migraine Disorders, sponsored by MJHS Institute for Innovation in Palliative Care.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 2
- Study locations
NCT03874351: Completed NA study of Migraine Disorders, sponsored by MJHS Institute for Innovation in Palliative Care.
NCT03874351 is a NA study of Migraine Disorders that has completed, run by MJHS Institute for Innovation in Palliative Care. The registered enrollment target is 22 participants, below the 314-participant average among 21 other Migraine Disorders trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03874351, a NA study of Migraine Disorders, has completed, sponsored by MJHS Institute for Innovation in Palliative Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 2
- Study locations
Study Summary
There is a need for better preventive and abortive therapies for migraine. Previous research has indicated that non-invasive neurostimulation may have prophylactic effects on migraine and improve symptoms and functional outcomes in migraineurs. One such method is a non-invasive transcranial direct current stimulation (tDCS). This double-blind randomized sham-controlled two-parallel-arm study aims to evaluate efficacy and safety of tDCS self-delivered in daily 20-minute applications for 2 months (60 days) by adult migraine patients at home for migraine prevention and migraine symptom management, as compared to sham tDCS application; and to evaluate patients' satisfaction with the procedure.
Primary Outcome
A migraine day is defined as any calendar day on which the patient had onset, continuation, or recurrence of a migraine as recorded in the diary. A migraine is defined as a migraine (with or without aura) lasting at least 30 minutes. Any calendar day on which acute migraine medication is used is counted as a migraine day.
Conditions Studied
Interventions
- DEVICE non-invasive transcranial direct current stimulation (tDCS)
Study Locations (2)
New York
- MJHS Institute for Innovation in Palliative Care - New York
- New York Headache Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2019-04-22 |
| Est. Completion | 2020-05-12 |
| Phase | NA |
What the finished NCT03874351 record still lists
NCT03874351 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 314-participant average among 21 other Migraine Disorders trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Migraine Disorders appearing as the primary indexed condition, and to 1 intervention - of which non-invasive transcranial direct current stimulation (tDCS) is the first listed.
NCT03874351 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03874351 about?
NCT03874351 is a clinical study titled "A Study of Home-Delivered Neurostimulation for Migraine". There is a need for better preventive and abortive therapies for migraine. Previous research has indicated that non-invasive neurostimulation may have prophylactic effects on migraine and improve symptoms and functional outcomes in migraineurs. One such method is a non-invasive transcranial direct c...
What is the current status of trial NCT03874351?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2019-04-22. Estimated completion is 2020-05-12.
What conditions does trial NCT03874351 study?
This clinical trial studies the following conditions: Migraine Disorders.
What interventions are being tested in trial NCT03874351?
The interventions under investigation include: non-invasive transcranial direct current stimulation (tDCS) (DEVICE).
Who is sponsoring clinical trial NCT03874351?
This trial is sponsored by MJHS Institute for Innovation in Palliative Care, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03874351 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03874351's enrollment target sits among peer trials
22 19th of 21 higher than 3 of 21 other Migraine Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Migraine Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
-
Mind Body Balance for Pediatric Migraine
RECRUITING · NA
-
Intervention for Sleep and Pain in Youth: a Randomized Controlled Trial
ACTIVE NOT RECRUITING · NA
-
Non-invasive Vagus Nerve Stimulation for the Prevention of Migraines
COMPLETED · NA
-
Integrative Migraine Pain Alleviation Through Chiropractic Therapy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI